Ventyx Biosciences (VTYX) Revenue & Revenue Breakdown
Ventyx Biosciences Revenue Highlights
00
Ventyx Biosciences Revenue by Period
Ventyx Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Ventyx Biosciences generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Ventyx Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $1.45M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $1.08M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Ventyx Biosciences generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Ventyx Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals | $179.28M | $69.46M |
| PRTA | Prothena | $135.16M | $2.42M |
| GOSS | Gossamer Bio | $114.70M | $13.29M |
| RGNX | REGENXBIO | $83.33M | $29.73M |
| VSTM | Verastem | $10.00M | $11.24M |
| ABSI | Absci | $4.53M | $378.00K |
| CRVS | Corvus Pharmaceuticals | - | - |
| VTYX | Ventyx Biosciences | - | - |
| KALV | KalVista Pharmaceuticals | - | $13.69M |
| MLTX | MoonLake Immunotherapeutics | - | - |
| OLMA | Olema Pharmaceuticals | - | - |